FFIV vs STRO
F5 Networks Inc (FFIV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. Revenue was up 9.7% from 2024-09-30 to 2025-09-30. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the FFIV and STRO stock pages for the full models.
Not investment advice.